Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 24

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

505

HTML

5480

Figures (1-3)

212

Tables (1-3)

145

Sum=6342

Jun 28, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jun 28, 2010; 16(24): 2963-2970
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.2963

Table 1 Receptor binding affinities of somatostatin, octreotide and lanreotide

	sst₁	sst₂	sst₃	sst₄	sst₅
Receptor binding affinity (IC₅₀ nmol/L)
Somatostatin[12]	0.93	0.15	0.56	1.50	0.29
Octreotide[12]	280.00	0.38	7.10	> 1000	6.30
Lanreotide[13]	> 1000	0.80	107	> 1000	5.20

Citation: Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16(24): 2963-2970
URL: https://www.wjgnet.com/1007-9327/full/v16/i24/2963.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i24.2963